title: High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon.
abstract: BACKGROUND
  A program, supported by the GEMHEP (Groupe d'étude Moléculaire des Hépatites), was established in 2007 in the sanitary district of Tokombéré, to prevent perinatal transmission of hepatitis B virus (HBV). It comprises screening for HBV surface antigen (HBsAg) in all pregnant women and vaccinating the newborn if tests are positive.
  
  
  RESULTS
  1276 women were enrolled in the study after providing informed consent. Demographic data and blood samples were available for 1267 of the enrolled patients. HBsAg was determined locally using a rapid test (Vikia HBsAg, Biomerieux). Tests for HBV and HDV virological markers (HBeAg, anti-HDV antibodies (Ab), HBV-DNA, HDV-RNA, HBV and HDV genotypes) were performed on the confirmed HBsAg-positive samples in the virology unit of the Angers University Hospital (France). HBsAg was found in 259 of the 1267 pregnant women (20.4%) between January 2009 and April 2010, of whom 59 were HBeAg-positive (22.7%) with high levels of HBV-DNA. Anti-HDV Ab were found in 19 (7.3%) of the HBsAg-positive women. The prevalence rates of HBsAg and HDV were not age-dependent whereas HBeAg carriers were statistically younger than non carriers. Basal core promoter (BCP) and precore (PC) mutations and genotypes were determined by sequencing. Of 120 amplified sequences, 119 belonged to HBV genotype E (HBV/E) and the 9 HDV strains belonged to HDV clade 1. In the PC region, 83/228 patients (36.4%) harbored a G1896A mutant or mixed phenotype virus. In the BCP region, the double mutation A1762T/G1764A and the G1757A substitution were detected respectively in 26/228 patients (11.4%) and 189/228 patients (82.8%).
  
  
  CONCLUSIONS
  Our results confirm the high prevalence and low molecular diversity of HBV in Far Northern Cameroon; more than 20% of the infected women were highly viremic, suggesting a high rate of HBV perinatal transmission and supporting the WHO recommendation to vaccinate at birth against hepatitis B.
authors.affiliation: Department of Bacteriology and Virology, Angers University Hospital, and HIFIH Laboratory, UPRES 3859, SFR 4208, Angers Cedex 9, France.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Ducancelle
authors.forename: Pierre
authors.initials: P
authors.lastname: Abgueguen
authors.forename: Jacques
authors.initials: J
authors.lastname: Birguel
authors.forename: Wael
authors.initials: W
authors.lastname: Mansour
authors.forename: Adeline
authors.initials: A
authors.lastname: Pivert
authors.forename: Hélène
authors.initials: H
authors.lastname: Le Guillou-Guillemette
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Sobnangou
authors.forename: Amélie
authors.initials: A
authors.lastname: Rameau
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Huraux
authors.forename: Françoise
authors.initials: F
authors.lastname: Lunel-Fabiani
mesh_terms: D000293:Adolescent; D000328:Adult; D002163:Cameroon / Q000453:epidemiology; D005260:Female; D014644:Genetic Variation; D005838:Genotype; D006509:Hepatitis B / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission / Q000821:virology; D006514:Hepatitis B Surface Antigens / Q000235:genetics / Q000276:immunology; D006513:Hepatitis B e Antigens / Q000235:genetics / Q000276:immunology; D006515:Hepatitis B virus / Q000145:classification / Q000235:genetics* / Q000276:immunology*; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D010641:Phenotype; D011247:Pregnancy; D015995:Prevalence; D012424:Rural Population; D012703:Serotyping; D019562:Viral Load; D055815:Young Adult
chemical_list: D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens